Sequence variants within the 3'-UTR of the COL5A1 gene alters mRNA stability: Implications for musculoskeletal soft tissue injuries

Matrix Biology

Volumn 30, Issue 5-6, 2011, Pages 338-345

  Laguette, Mary Jessica ^a   Abrahams, Yoonus ^a   Prince, Sharon ^a   Collins, Malcolm ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

Flexibility; Ligament; MiRNA; Tendon; Type V collagen

Indexed keywords

FIREFLY LUCIFERASE; MESSENGER RNA; MICRORNA;

3' UNTRANSLATED REGION; ACHILLES TENDINITIS; ALLELE; ARTICLE; ASSAY; COL5A1 GENE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE DELETION; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; MUSCULOSKELETAL INJURY; PRIORITY JOURNAL; RNA BINDING; RNA STABILITY; SOFT TISSUE INJURY;

3' UNTRANSLATED REGIONS; ACHILLES TENDON; ADULT; ALLELES; BASE SEQUENCE; BINDING SITES; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CLONING, MOLECULAR; COLLAGEN TYPE V; GENES, REPORTER; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA STABILITY; SOFT TISSUE INJURIES; TRANSFECTION;

EID: 79960563794     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2011.05.001     Document Type: Article

References (32)

1. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum. 2010, 62:1361-1371.
2. Birk D.E. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001, 32:223-237.
3. Birk D.E., Fitch J.M., Babiarz J.P., Doane K.J., Linsenmayer T.F. Collagen fibrillogenesis in vitro: interaction of types I and V collagen regulates fibril diameter. J. Cell. Sci. 1990, 95:649-657.
4. Brown, J.C., Miller, C., Posthumus, M., Schwellnus, M., Collins, M. The COL5A1 gene, ultra-marathon running performance and range of motion. Int J Sports Physiol Perform. in press.
5. Brown J.C., Miller C., Schwellnus M.P., Collins M. Range of motion measurements diverge with increasing age for COL5A1 genotypes. Scand J Med Sci Sports 2011, 10.1111/j.1600-0838.2010.01271.x.
6. Chanut-Delalande H., Bonod-Bidaud C., Cogne S., Malbouyres M., Ramirez F., Fichard A., Ruggiero F. Development of a functional skin matrix requires deposition of collagen V heterotrimers. Mol. Cell. Biol. 2004, 24:6049-6057.
7. Collins M., Mokone G.G., September A.V., van der Merwe L., Schwellnus M.P. The COL5A1 genotype is associated with range of motion measurements. Scand. J. Med. Sci. Sports 2009, 19:803-809.
8. Conne B., Stutz A., Vassalli J.D. The 3' untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat. Med. 2000, 6:637-641.
9. Du B., Ma L.M., Huang M.B., Zhou H., Huang H.L., Shao P., Chen Y.Q., Qu L.H. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett. 2010, 584:811-816.
10. Garzon R., Calin G.A., Croce C.M. MicroRNAs in cancer. Annu. Rev. Med. 2009, 60:167-179.
11. Griffiths-Jones S. The microRNA registry. Nucleic Acids Res. 2004, 32:D109-D111.
12. Hiard S., Charlier C., Coppieters W., Georges M., Baurain D. Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Res. 2010, 38:D640-D651.
13. Kadler K.E., Baldock C., Bella J., Boot-Handford R.P. Collagens at a glance. J. Cell. Sci. 2007, 120:1955-1958.
14. Kaufman K.R., Brodine S.K., Shaffer R.A., Johnson C.W., Cullison T.R. The effect of foot structure and range of motion on musculoskeletal overuse injuries. Am. J. Sports Med. 1999, 27:585-593.
15. Liu X., Yu J., Jiang L., Wang A., Shi F., Ye H., Zhou X. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 2009, 6:131-139.
16. Malfait F., Wenstrup R.J., De Paepe A. Clinical and genetic aspects of Ehlers-Danlos syndrome, classic type. Genet. Med. 2010, 12:597-605.
17. Mazumder B., Seshadri V., Fox P.L. Translational control by the 3'-UTR: the ends specify the means. Trends Biochem. Sci. 2003, 28:91-98.
18. Meola N., Gennarino V.A., Banfi S. microRNAs and genetic diseases. Pathogenetics 2009, 2:7.
19. Mokone G.G., Schwellnus M.P., Noakes T.D., Collins M. The COL5A1 gene and Achilles tendon pathology. Scand. J. Med. Sci. Sports 2006, 16:19-26.
20. Ogawa T., Iizuka M., Sekiya Y., Yoshizato K., Ikeda K., Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem. Biophys. Res. Commun. 2010, 391:316-321.
21. Posthumus M., September A.V., O'Cuinneagain D., van der Merwe W., Schwellnus M.P., Collins M. The COL5A1 gene is associated with increased risk of anterior cruciate ligament ruptures in female participants. Am. J. Sports Med. 2009, 37:2234-2240.
22. Posthumus M., Schwellnus M.P., Collins M. The COL5A1Gene: a novel marker of endurance running performance. Med. Sci. Sports Exerc. 2011, 43:584-589.
23. Ross J. mRNA stability in mammalian cells. Microbiol. Rev. 1995, 59:423-450.
24. Scoumanne A., Cho S.J., Zhang J., Chen X. The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability. Nucleic Acids Res. 2011, 39:213-224.
25. September A.V., Cook J., Handley C.J., van der Merwe L., Schwellnus M.P., Collins M. Variants within the COL5A1 gene are associated with Achilles tendinopathy in two populations. Br. J. Sports Med. 2009, 43:357-365.
26. Thiele B.J., Doller A., Kahne T., Pregla R., Hetzer R., Regitz-Zagrosek V. RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis. Circ. Res. 2004, 95:1058-1066.
27. Uhorchak J.M., Scoville C.R., Williams G.N., Arciero R.A., St Pierre P., Taylor D.C. Risk factors associated with noncontact injury of the anterior cruciate ligament: a prospective four-year evaluation of 859 West Point cadets. Am. J. Sports Med. 2003, 31:831-842.
28. Vogel A., Holbrook K.A., Steinmann B., Gitzelmann R., Byers P.H. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. Lab. Invest. 1979, 40:201-206.
29. Wang G., van der Walt J.M., Mayhew G., Li Y.J., Zuchner S., Scott W.K., Martin E.R., Vance J.M. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 2008, 82:283-289.
30. Wenstrup R., De Paepe A. Ehlers-Danlos syndrome, classic type. GeneReviews 2010, University of Washington, Seattle (WA). R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens (Eds.).
31. Wenstrup R.J., Florer J.B., Brunskill E.W., Bell S.M., Chervoneva I., Birk D.E. Type V collagen controls the initiation of collagen fibril assembly. J. Biol. Chem. 2004, 279:53331-53337.
32. Wenstrup R.J., Florer J.B., Davidson J.M., Phillips C.L., Pfeiffer B.J., Menezes D.W., Chervoneva I., Birk D.E. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages. J. Biol. Chem. 2006, 281:12888-12895.